Pure Global
NCT06334601

Diurnal Evaluation of OSA Upper Airway Collapsibility and Muscle Responsiveness

Diurnal Evaluation of Obstructive Sleep Apnea (OSA) Upper Airway Collapsibility and Muscle Responsiveness
Istituto Auxologico Italiano·ClinicalTrials.gov·diagnostic testRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Obstructive Sleep Apnea
Drug/Device/Intervention
Tests of upper airway collapsibility and muscle responsiveness.
Study type
Observational
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
Istituto Auxologico Italiano
Location
Milano, Italy
Timeline & enrollment
Phase
N/A
Start date
Jan 15, 2023
End date
Dec 31, 2025
Enrollment
66 participants
Primary outcome

Upper airway collapsibility,Upper airway muscle responsiveness

Summary

In the framework of pathophysiological trait in obstructive sleep apnea (OSA) patients, a
 simplified method is proposed to measure upper airway (UA) collapsibility and muscle
 responsiveness during wakefulness.

ICD-10 classifications
Sleep apnoeaSleep disordersSleep disorder, unspecifiedPrimary sleep apnoea of newbornNonorganic sleep disorders
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06334601
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06334601 through Pure Global AI's free database. This phase not specified trial is sponsored by Istituto Auxologico Italiano and is currently Recruiting. The study focuses on Obstructive Sleep Apnea. Target enrollment is 66 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.